IL17A and cancer: Certain inflammatory cytokines, such as IL-6 and IL-17, are diagnostic markers for early phase of inflammation and they interact in the promotion of tumors and cancer progression and they act in the regulation of Cu uptake mechanisms, thus contributing to the accumulation of Cu in cancer cells (24, 43).